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Foot and mouth disease (FMD) is a highly 
contagious viral disease affecting domestic 
and wild artiodactyl animals. Its causative 
agent is foot-and–mouth disease virus 
(FMDV: Aphtovirus, Picornaviridae). Seven 
immunologically distinct serotypes (O, A, C, 
Asia1, SAT 1, SAT 2 and SAT 3) and many 
subtypes are described worldwide. FMD is 
one of the most economically devastating 
diseases of livestock. It is enzootic in many 
parts of the world including sub-Saharan 
Africa. Most studies on FMD are carried out 
in countries where control measures are 
implemented. On the other hand, in regions 
such as sub-Saharan Africa, where FMD is 
endemic and new strains are likely to 
spread due to animal movements, there are 
very few published studies on FMDV 
molecular epidemiology. In Chad 
particularly, no studies have been 
conducted to investigate circulating FMDV 
strains. 
 
This work aims to understand the 
transmission process of FMDV in the 
pastoral area of Chad, based on a stratified 
sample of livestock herds (fig. 1). 
Susceptible animals (cattle, sheep, goats, and 
camels) were sampled according to the a priori 
risk of FMD spread in Chad, evaluated by a 
qualitative risk analysis combining the risks of 
its introduction and dissemination. 
In total, 2,195 sera and eight epithelium samples were collected from October to December 2016 
in six districts (Batha-Ouest, Batha-Est, Ennedi-Ouest, Wadi-fira, Chari and Lac Wey). Five out of 
the eight samples tested positive by real-time RT-PCR targeting the FMDV IRES region or the 
FMDV 3D polymerase coding region. Further analyses targeting specifically the VP1 coding region 
showed SAT2 type for four samples out of these five FMDV positive samples. Finally amplification 
and sequencing of the VP1 coding region of these four SAT2 positive samples was carried out to 
characterize more precisely the strains. Preliminary results were obtained for one sample, 
confirming the presence of a SAT2 virus, closely related to FMDV SAT2 viruses isolated in Egypt in 
2012. Serological analyses are pending. 
Filling the gap of knowledge concerning the FMDV strains circulating in Chad could both 
contribute to a better selection of vaccine strains but also to an update of the available molecular 
epidemiology data of FMD virus in sub-Saharan Africa in general.  
Figure 1: Risk of FMDV spread in 
Chad (based on data collected in 
2016)  
